IM Cannabis Corp. Common Shares
IMCCIM Cannabis Corp. is a multinational company focused on the production and distribution of medical cannabis products. Established to capitalize on the growing medical marijuana industry, it operates in various jurisdictions, offering a range of cannabis-based treatments and products. The company emphasizes quality cultivation, research, and strategic partnerships to expand its presence in the legal cannabis market.
Company News
IM Cannabis Corp. (NASDAQ: IMCC) announced the closing of a US$225,000 convertible note financing with an institutional investor. The convertible note bears 8% interest (increasing to 14% upon default) and includes warrants to purchase 781,250 common shares at C$0.40 per share. The company intends to use net proceeds for general corporate purpose...
IM Cannabis Corp. (NASDAQ: IMCC) reported Q1 2026 results with revenues of $8.7 million, gross profit of $1.4 million, and a net loss of $2.5 million ($0.38 per share). The company reduced general and administrative expenses by 22% year-over-year and completed convertible note financings to support liquidity management. Operations continue in Isr...
IM Cannabis Corp (NASDAQ: IMCC) announced the closing of convertible note financings totaling US$550,000 in gross proceeds. The company issued two convertible notes with warrants to institutional investors, with net proceeds to be used for general corporate purposes. The notes feature conversion prices tied to market conditions and include standa...
IM Cannabis Corp. reported 2025 full-year revenue of C$54.7 million with strong 134% growth in Germany, now representing 66% of total revenue. The company achieved positive operating cash flow of C$4.7 million, a significant turnaround from 2024, and strengthened its cash position to C$3.3 million through strategic financings. Additionally, IMC a...
IM Cannabis Corp. (NASDAQ:IMCC) announced it has raised US$2.17 million through two note purchase agreements with a third-party lender to manage liquidity requirements. The First Note of US$1.54 million and Second Note of US$632,911.50 both carry 8% interest (increasing to 14% upon default) with 18-month maturities and conversion options. Approxi...
